Foxp1/2/4 regulate endochondral ossification as a suppresser complex

Developmental Biology

Volumn 398, Issue 2, 2015, Pages 242-254

  Zhao, Haixia ^a   Zhou, Wenrong ^a   Yao, Zhengju ^a   Wan, Yong ^a   Cao, Jingjing ^a   Zhang, Lingling ^a   Zhao, Jianzhi ^a   Li, Hanjun ^a   Zhou, Rujiang ^a   Li, Baojie ^a   Wei, Gang ^b   Zhang, Zhenlin ^c   French, Catherine A ^d   Dekker, Joseph D ^e   Yang, Yingzi ^f   Fisher, Simon E ^g,h   Tucker, Haley O ^e   Guo, Xizhi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^d CHAMPALIMAUD CENTRE FOR THE UNKNOWN   (Portugal)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g MAX PLANCK INSTITUTE FOR PSYCHOLINGUISTICS   (Netherlands)

^h RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Endochondral ossification; Foxp1; Foxp2; Foxp4; Osteoblast; Transcriptional repressor

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR FOXP2; TRANSCRIPTION FACTOR FOXP4; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; CRE RECOMBINASE; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, MOUSE; FOXP2 PROTEIN, MOUSE; FOXP4 PROTEIN, MOUSE; INTEGRASE; PROTEIN BINDING; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; ENCHONDRAL OSSIFICATION; FOXP1 GENE; FOXP2 GENE; FOXP4 GENE; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GROWTH PLATE; HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; OSTEOBLAST; PERICHONDRIUM; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STEM CELL; ANIMAL; BONE; BONE MINERALIZATION; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DEFICIENCY; EMBRYOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; LIMB; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

MUS;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CERCOPITHECUS AETHIOPS; CHONDROCYTES; CHONDROGENESIS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; COS CELLS; EXTREMITIES; FORKHEAD TRANSCRIPTION FACTORS; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HUMANS; HYPERTROPHY; INTEGRASES; MICE, TRANSGENIC; OSTEOGENESIS; PROTEIN BINDING; REPRESSOR PROTEINS;

EID: 84922711705     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2014.12.007     Document Type: Article

References (57)

1. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., Deng J.M., Taketo M.M., Nakamura T., Behringer R.R., McCrea P.D., de Crombrugghe B. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 2004, 18:1072-1087.
2. Almeida M. Unraveling the role of FoxOs in bone-insights from mouse models. Bone 2011, 49:319-327.
3. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 1990, 30:109-116.
4. Augello M.A., Hickey T.E., Knudsen K.E. FOXA1: master of steroid receptor function in cancer. EMBO J. 2011, 30:3885-3894.
5. Bialek P., Kern B., Yang X., Schrock M., Sosic D., Hong N., Wu H., Yu K., Ornitz D.M., Olson E.N., Justice M.J., Karsenty G. A twist code determines the onset of osteoblast differentiation. Dev. Cell 2004, 6:423-435.
6. Chen Z., Xiao Y., Zhang J., Li J., Liu Y., Zhao Y., Ma C., Luo J., Qiu Y., Huang G., Korteweg C., Gu J. Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells. PLoS One 2011, 6:e20475.
7. Correa D., Hesse E., Seriwatanachai D., Kiviranta R., Saito H., Yamana K., Neff L., Atfi A., Coillard L., Sitara D., Maeda Y., Warming S., Jenkins N.A., Copeland N.G., Horne W.C., Lanske B., Baron R. Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev. Cell 2010, 19:533-546.
8. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 2005, 8:739-750.
9. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
10. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 1995, 15:1858-1869.
11. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
12. Duhen T., Duhen R., Lanzavecchia A., Sallusto F., Campbell D.J. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 2012, 119:4430-4440.
13. Eijkelenboom A., Burgering B.M. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 2013, 14:83-97.
14. Feng X., Ippolito G.C., Tian L., Wiehagen K., Oh S., Sambandam A., Willen J., Bunte R.M., Maika S.D., Harriss J.V., Caton A.J., Bhandoola A., Tucker P.W., Hu H. Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 2009, 115:510-518.
15. French C.A., Groszer M., Preece C., Coupe A.M., Rajewsky K., Fisher S.E. Generation of mice with a conditional Foxp2 null allele. Genesis. 2007, 45:440-446.
16. Funato N., Chapman S.L., McKee M.D., Funato H., Morris J.A., Shelton J.M., Richardson J.A., Yanagisawa H. Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2. Development 2009, 136:615-625.
17. Gabut M., Samavarchi-Tehrani P., Wang X., Slobodeniuc V., O'Hanlon D., Sung H.K., Alvarez M., Talukder S., Pan Q., Mazzoni E.O., Nedelec S., Wichterle H., Woltjen K., Hughes T.R., Zandstra P.W., Nagy A., Wrana J.L., Blencowe B.J. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011, 147:132-146.
18. Guo X., Day T.F., Jiang X., Garrett-Beal L., Topol L., Yang Y. Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 2004, 18:2404-2417.
19. Guo X., Mak K.K., Taketo M.M., Yang Y. The Wnt/beta-catenin pathway interacts differentially with PTHrP signaling to control chondrocyte hypertrophy and final maturation. PLoS One 2009, 4:e6067.
20. Hartmann C. Transcriptional networks controlling skeletal development. Curr. Opin. Genet. Dev. 2009, 19:437-443.
21. Hesse E., Saito H., Kiviranta R., Correa D., Yamana K., Neff L., Toben D., Duda G., Atfi A., Geoffroy V., Horne W.C., Baron R. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J. Cell Biol. 2010, 191:1271-1283.
22. Hinoi E., Bialek P., Chen Y.T., Rached M.T., Groner Y., Behringer R.R., Ornitz D.M., Karsenty G. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev. 2006, 20:2937-2942.
23. Hu H., Wang B., Borde M., Nardone J., Maika S., Allred L., Tucker P.W., Rao A. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 2006, 7:819-826.
24. Javed A., Chen H., Ghori F.Y. Genetic and transcriptional control of bone formation. Oral Maxillofac. Surg. Clin. N. Am 2010, 22:283-293.
25. Karsenty G. Transcriptional control of skeletogenesis. Annu. Rev. Genomics Hum. Genet. 2008, 9:183-196.
26. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2002, 2:389-406.
27. Katoh M., Igarashi M., Fukuda H., Nakagama H. Cancer genetics and genomics of human FOX family genes. Cancer Lett. 2013, 328:198-206.
28. Kobayashi T., Kronenberg H. Minireview: transcriptional regulation in development of bone. Endocrinology 2005, 146:1012-1017.
29. Kode A., Mosialou I., Silva B.C., Rached M.T., Zhou B., Wang J., Townes T.M., Hen R., DePinho R.A., Guo X.E., Kousteni S. FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin. J. Clin. Investig. 2012, 122:3490-3503.
30. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
31. Koon H.B., Ippolito G.C., Banham A.H., Tucker P.W. FOXP1: a potential therapeutic target in cancer. Expert Opin. Ther. Targets 2007, 11:955-965.
32. Korac P., Peran I., Skrtic A., Ajdukovic R., Kristo D.R., Dominis M. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma. Pathol. Int. 2009, 59:354-358.
33. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
34. Kume T. The role of FoxC2 transcription factor in tumor angiogenesis. J. Oncol. 2011, 2012:204593.
35. Li S., Wang Y., Zhang Y., Lu M.M., DeMayo F.J., Dekker J.D., Tucker P.W., Morrisey E.E. Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2. Development 2012, 139:2500-2509.
36. Li S., Weidenfeld J., Morrisey E.E. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol. Cell Biol. 2004, 24:809-822.
37. Logan M., Martin J.F., Nagy A., Lobe C., Olson E.N., Tabin C.J. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 2002, 33:77-80.
38. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 2012, 13:27-38.
39. Long F., Ornitz D.M. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 2013, 5:a008334.
40. Lu C., Wan Y., Cao J., Zhu X., Yu J., Zhou R., Yao Y., Zhang L., Zhao H., Li H., Zhao J., He L., Ma G., Yang X., Yao Z., Guo X. Wnt-mediated reciprocal regulation between cartilage and bone development during endochondral ossification. Bone 2013, 53:566-574.
41. Lu M.M., Li S., Yang H., Morrisey E.E. Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues. Mech. Dev. 2002, 119(Suppl. 1):S197-S202.
42. Maes C., Kobayashi T., Selig M.K., Torrekens S., Roth S.I., Mackem S., Carmeliet G., Kronenberg H.M. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 2010, 19:329-344.
43. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
44. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
45. Raychaudhuri P., Park H.J. FoxM1: a master regulator of tumor metastasis. Cancer Res. 2011, 71:4329-4333.
46. Shimizu E., Selvamurugan N., Westendorf J.J., Olson E.N., Partridge N.C. HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression. J. Biol. Chem. 2010, 285:9616-9626.
47. Shu W., Lu M.M., Zhang Y., Tucker P.W., Zhou D., Morrisey E.E. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 2007, 134:1991-2000.
48. Takahashi K., Liu F.C., Hirokawa K., Takahashi H. Expression of Foxp4 in the developing and adult rat forebrain. J. Neurosci. Res. 2008, 86:3106-3116.
49. Takarada T., Hinoi E., Nakazato R., Ochi H., Xu C., Tsuchikane A., Takeda S., Karsenty G., Abe T., Kiyonari H., Yoneda Y. An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. J. Bone Miner. Res. 2013, 28:2064-2069.
50. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., McAnally J., Pomajzl C., Shelton J.M., Richardson J.A., Karsenty G., Olson E.N. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566.
51. Wang B., Lin D., Li C., Tucker P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 2003, 278:24259-24268.
52. Wang B., Weidenfeld J., Lu M.M., Maika S., Kuziel W.A., Morrisey E.E., Tucker P.W. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 2004, 131:4477-4487.
53. Wang H., Geng J., Wen X., Bi E., Kossenkov A.V., Wolf A.I., Tas J., Choi Y.S., Takata H., Day T.J., Chang L.Y., Sprout S.L., Becker E.K., Willen J., Tian L., Wang X., Xiao C., Jiang P., Crotty S., Victora G.D., Showe L.C., Tucker H.O., Erikson J., Hu H. The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells. Nat. Immunol. 2014, 15:667-675.
54. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T., Li L., Brancorsini S., Sassone-Corsi P., Townes T.M., Hanauer A., Karsenty G. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004, 117:387-398.
55. Yang Y., Topol L., Lee H., Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 2003, 130:1003-1015.
56. Yoshida C.A., Yamamoto H., Fujita T., Furuichi T., Ito K., Inoue K., Yamana K., Zanma A., Takada K., Ito Y., Komori T. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 2004, 18:952-963.
57. Zhang Y., Li S., Yuan L., Tian Y., Weidenfeld J., Yang J., Liu F., Chokas A.L., Morrisey E.E. Foxp1 coordinates cardiomyocyte proliferation through both cell-autonomous and nonautonomous mechanisms. Genes Dev. 2010, 24:1746-1757.